tradingkey.logo
tradingkey.logo
Pesquisar

Bone Biologics Corp

BBLGW
Adicionar à lista de desejos
15.000USD
0.0000.00%
Fechamento 07/07, 16:00ETCotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM

Mais detalhes de Bone Biologics Corp Empresa

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Informações de Bone Biologics Corp

Código da empresaBBLGW
Nome da EmpresaBone Biologics Corp
Data de listagemNov 27, 2015
CEOMr. Jeffrey Frelick
Número de funcionários- -
Tipo de títulosCompany Warrant
Fim do ano fiscal- -
Endereço2 Burlington Woods Dr Ste 100
CidadeBURLINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal01803-4551
Telefone17815524452
Sitehttps://www.bonebiologics.com/
Código da empresaBBLGW
Data de listagemNov 27, 2015
CEOMr. Jeffrey Frelick

Executivos da empresa Bone Biologics Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Bone Biologics Corp?

Os cinco principais acionistas de Bone Biologics Corp são: Mr. Jody Cain